Edition:
India

Syndax Pharmaceuticals Inc (SNDX.OQ)

SNDX.OQ on NASDAQ Stock Exchange Global Select Market

8.25USD
22 Nov 2017
Change (% chg)

$-0.03 (-0.36%)
Prev Close
$8.28
Open
$8.31
Day's High
$8.44
Day's Low
$8.03
Volume
65,409
Avg. Vol
37,865
52-wk High
$15.65
52-wk Low
$6.38

Select another date:

Wed, Nov 8 2017

BRIEF-Syndax Pharmaceuticals reports Q3 loss per share $0.68

* Syndax pharmaceuticals reports third quarter 2017 financial results and provides clinical and business update

BRIEF-Syndax announces $25 million registered direct offering of common stock

* Syndax announces $25 million registered direct offering of common stock

BRIEF-Syndax Pharma enters into license agreement with unit of Allergan

* On Oct 13, co entered into license agreement with Vitae Pharmaceuticals, a subsidiary of Allergan Plc​ - SEC filing

BRIEF-‍Syndax announces dosing of first patient in trial of Entinostat for treatment of recurrent breast cancer

* ‍Syndax announces dosing of first patient in pivotal trial of entinostat for treatment of advanced or recurrent breast cancer in Japan by partner kyowa hakko kirin​

BRIEF-Syndax Pharmaceuticals Q2 loss per share $0.70

* Syndax Pharmaceuticals reports second quarter 2017 financial results and provides clinical and business update

BRIEF-Syndax prices public offering of common stock

* Pricing of an underwritten public offering of 3.7 million shares of its common stock at a price to public of $13.25 per share Source text for Eikon: Further company coverage:

BRIEF-Syndax Pharma to offer common stock in public offering

* Syndax pharmaceuticals inc- it plans to offer and sell $50 million of its common stock in an underwritten public offering Source text for Eikon: Further company coverage:

Select another date: